97 related articles for article (PubMed ID: 7811262)
1. Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.
Roher AE; Kasunic TC; Woods AS; Cotter RJ; Ball MJ; Fridman R
Biochem Biophys Res Commun; 1994 Dec; 205(3):1755-61. PubMed ID: 7811262
[TBL] [Abstract][Full Text] [Related]
2. A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.
Miyazaki K; Hasegawa M; Funahashi K; Umeda M
Nature; 1993 Apr; 362(6423):839-41. PubMed ID: 8479521
[TBL] [Abstract][Full Text] [Related]
3. Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence.
Esler WP; Stimson ER; Ghilardi JR; Lu YA; Felix AM; Vinters HV; Mantyh PW; Lee JP; Maggio JE
Biochemistry; 1996 Nov; 35(44):13914-21. PubMed ID: 8909288
[TBL] [Abstract][Full Text] [Related]
4. A novel metalloprotease in rat brain cleaves the amyloid precursor protein of Alzheimer's disease generating amyloidogenic fragments.
Mok SS; Evin G; Li QX; Smith AI; Beyreuther K; Masters CL; Small DH
Biochemistry; 1997 Jan; 36(1):156-63. PubMed ID: 8993329
[TBL] [Abstract][Full Text] [Related]
5. Effect of Ca2+ on the secondary structure of linear and cyclic collagen sequence analogs.
Likó Z; Botyánszki J; Bódi J; Vass E; Majer Z; Hollósi M; Süli-Vargha H
Biochem Biophys Res Commun; 1996 Oct; 227(2):351-9. PubMed ID: 8878520
[TBL] [Abstract][Full Text] [Related]
6. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
7. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
9. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
10. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
11. "Click peptides"--chemical biology-oriented synthesis of Alzheimer's disease-related amyloid beta peptide (abeta) analogues based on the "O-acyl isopeptide method".
Sohma Y; Kiso Y
Chembiochem; 2006 Oct; 7(10):1549-57. PubMed ID: 16915597
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
Rice A; Banda MJ
Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
[TBL] [Abstract][Full Text] [Related]
13. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H; Takino T; Okada Y; Cao J; Shinagawa A; Yamamoto E; Seiki M
Nature; 1994 Jul; 370(6484):61-5. PubMed ID: 8015608
[TBL] [Abstract][Full Text] [Related]
14. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice.
Itoh T; Ikeda T; Gomi H; Nakao S; Suzuki T; Itohara S
J Biol Chem; 1997 Sep; 272(36):22389-92. PubMed ID: 9278386
[TBL] [Abstract][Full Text] [Related]
15. Thioester hydrolysis by matrix metalloproteinases.
Stein RL; Izquierdo-Martin M
Arch Biochem Biophys; 1994 Jan; 308(1):274-7. PubMed ID: 8311464
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptide products from enzymatic degradation of amyloid beta.
Rogeberg M; Furlund CB; Moe MK; Fladby T
Biochimie; 2014 Oct; 105():216-20. PubMed ID: 25010651
[TBL] [Abstract][Full Text] [Related]
17. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A).
Bányai L; Tordai H; Patthy L
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):403-7. PubMed ID: 8135748
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function.
Gohlke U; Gomis-Rüth FX; Crabbe T; Murphy G; Docherty AJ; Bode W
FEBS Lett; 1996 Jan; 378(2):126-30. PubMed ID: 8549817
[TBL] [Abstract][Full Text] [Related]
19. Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments.
Papastoitsis G; Siman R; Scott R; Abraham CR
Biochemistry; 1994 Jan; 33(1):192-9. PubMed ID: 8286339
[TBL] [Abstract][Full Text] [Related]
20. Selective localization of gelatinase A, an enzyme degrading beta-amyloid protein, in white matter microglia and in Schwann cells.
Yamada T; Miyazaki K; Koshikawa N; Takahashi M; Akatsu H; Yamamoto T
Acta Neuropathol; 1995; 89(3):199-203. PubMed ID: 7538720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
